Your session is about to expire
← Back to Search
Group Written Exposure Therapy for PTSD (GWET Trial)
N/A
Recruiting
Led By Jenna Boyd, Ph.D.
Research Sponsored by St. Joseph's Healthcare Hamilton
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week before treatment begins, 1 week after treatment ends, and 1-month follow-up.
Awards & highlights
No Placebo-Only Group
Summary
"This trial aims to see if Written Exposure Therapy (WET) is effective when done in a group setting for patients with post-traumatic stress disorder (PTSD). They want to know if group W
Who is the study for?
This trial is for adults aged 18-65 with PTSD who can read and write in English. They must be able to give informed consent. It's not clear what excludes someone from participating, but typically it would involve factors that could interfere with the treatment or data collection.
What is being tested?
The trial tests Group Written Exposure Therapy (WET) for PTSD, comparing its effectiveness and dropout rates against group Cognitive Processing Therapy (CPT). Participants will attend six weekly online sessions led by therapists and complete symptom questionnaires over time.
What are the potential side effects?
While specific side effects are not listed, psychological therapies like WET may sometimes cause temporary increases in distress due to discussing traumatic events, which should be monitored by the therapists.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ weekly at each group session, 1 week before treatment begins, 1 week after treatment ends, and 1-month follow-up.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weekly at each group session, 1 week before treatment begins, 1 week after treatment ends, and 1-month follow-up.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change from baseline on the PTSD Checklist for DSM-5 (PCL-5)
Secondary study objectives
Change from baseline on the Depression, Anxiety, Stress Scale -21 Item Version (DASS-21)
Change from baseline on the Difficulties in Emotion Regulation Scale (DERS)
Change from baseline on the Illness Intrusiveness Rating Scale (IIRS)
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Group Written Exposure TherapyExperimental Treatment1 Intervention
Patients will be invited to participate in group Written Exposure Therapy (described in the "Interventions" section).
Find a Location
Who is running the clinical trial?
St. Joseph's Healthcare HamiltonLead Sponsor
202 Previous Clinical Trials
26,862 Total Patients Enrolled
Jenna Boyd, Ph.D.Principal InvestigatorSt. Joseph's Healthcare Hamilton